DIA 2024 Global Annual Meeting

Attending this event?

DIA 2024 Global Annual Meeting

3:30pm PDT

#146: Past, Present, and Future: How Industry and FDA are Handling the Evolving Clinical Trial Diversity Regulatory Landscape Room 6A

8:00am PDT

#203: Feasible Site Feasibility Assessments: Rethinking Business as Usual to Reduce Burden, Timelines, and Costs for Sustainability Room 6C

10:00am PDT

#220: Targeting Shared Molecular Etiologies to Accelerate Drug Development for Rare Diseases Room 5AB #222: External Control Arms at Scale: Multicenter, Multisource Infrastructure for External Control Arms Room 11AB #221: Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology Room 6F

1:15pm PDT

#246: The State of Clinical Trials in 2024: Are We Making the Grade? Room 11AB

3:15pm PDT

#265: Practical Approaches and Resources to Optimize Advocacy Group - Industry Collaborations: An Update on the PALADIN Consortium Room 5AB #264: Advancing Innovation in Clinical Trial Design and Conduct Room 6A

4:30pm PDT

#280: Innovation, Agility, and Accessibility in Trial Execution: Exploring the Roles, Pathways, and Potential for Integration of Embedded Clinics, Pharmacies, and Diagnostic Providers in Clinical Research at Sc... Room 1AB #279: Accelerating Innovation Through Design: Integrating Real-World Data into Clinical Trials Room 6F

10:00am PDT

#318: Defining an Inclusive Clinical Trials Approach in Europe Room 6F

1:15pm PDT

#349: Study Design for Cell and Gene Therapy Trials: Regulatory Overview, Challenges, and Updates Room 15AB

4:30pm PDT

#374: Updated Status of Multiregional Clinical Trials Based on ICH E17 Guideline: 5 Years After the Implementation Room 5AB

8:00am PDT

#404: Meeting in the Middle: Best Practices for Collaboration Between Medical Affairs and Clinical Development Room 8